Related references
Note: Only part of the references are listed.Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain
C. Z. Zhu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective
Matthias Karst et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
CB2 receptors in the brain: role in central immune function
G. A. Cabral et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Nabilone for the treatment of pain in fibromyalgia
Ryan Quinlan Skrabek et al.
JOURNAL OF PAIN (2008)
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone:: A potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration
Edward K. Dziadulewicz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Nitin Agarwal et al.
NATURE NEUROSCIENCE (2007)
Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain -: A double-blind placebo-controlled cross-over trial
Joerg Wissel et al.
JOURNAL OF NEUROLOGY (2006)
Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat
A Dyson et al.
PAIN (2005)
CB1 cannabinoid receptor stimulation modulates transient receptor potential vanilloid receptor 1 activities in calcium influx and substance P release in cultured rat dorsal root ganglion cells
K Oshita et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
S Akerman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons
IA Khasabova et al.
JOURNAL OF NEUROSCIENCE (2004)
Ajulemic acid: A novel cannabinoid produces analgesia without a high
SH Burstein et al.
LIFE SCIENCES (2004)
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial
JS Berman et al.
PAIN (2004)
Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury
LM Johanek et al.
PAIN (2004)
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain - A randomized controlled trial
M Karst et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Cannabinoid agonists attenuate capsaicin-induced responses in human skin
R Rukwied et al.
PAIN (2003)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
A peripheral cannabinoid mechanism suppresses spinal Fos protein expression and pain behavior in a rat model of inflammation
AG Nackley et al.
NEUROSCIENCE (2003)
Cannabinoid analgesia
JM Walker et al.
PHARMACOLOGY & THERAPEUTICS (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain
D Bridges et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
A Fox et al.
PAIN (2001)
Share Paper
